fax: +39 02 63 63 2714
Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis†
Version of Record online: 29 SEP 2009
Copyright © 2009 American Association for the Study of Liver Diseases
Volume 51, Issue 2, pages 388–397, February 2010
How to Cite
Bruno, S., Shiffman, M. L., Roberts, S. K., Gane, E. J., Messinger, D., Hadziyannis, S. J. and Marcellin, P. (2010), Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis. Hepatology, 51: 388–397. doi: 10.1002/hep.23340
Potential conflict of interest: Nothing to report.
- Issue online: 25 JAN 2010
- Version of Record online: 29 SEP 2009
- Accepted manuscript online: 29 SEP 2009 12:00AM EST
- Manuscript Accepted: 15 SEP 2009
- Manuscript Received: 28 APR 2009
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.